Chris Cameron

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 18

Top Topics

Metastatic Breast Cancer

Systematic Review

Multiple Sclerosis

Top Venues

Journal of comparative effectiveness research

Leukemia & lymphoma

Current medical research and opinion

Systematic reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Rena Buckstein, Lisa Chodirker, Karen W L Yee, Michelle Geddes, Heather A Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leukemia & lymphoma 64 (3) (2023)
Rena Buckstein, Lisa Chodirker, Karen W L Yee, Michelle Geddes, Heather A Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leukemia & lymphoma (2023)
Rena Buckstein, Lisa Chodirker, Karen W L Yee, Michelle Geddes, Heather A Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leukemia & lymphoma 64 (3) (2023)
Ernest H Law, Chris Cameron
Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant. Journal of comparative effectiveness research (2023)
Rena Buckstein, Lisa Chodirker, Karen W L Yee, Michelle Geddes, Heather A Leitch, Grace Christou, Versha Banerji, Brian Leber, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Anne Parmentier, Aksharh Thambipillai, Derek Tang, Christopher Westcott, Chris Cameron, Paul Spin
The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry. Leukemia & lymphoma (2023)
Rena Buckstein, Lisa Chodirker, Lee Mozessohn, Karen W L Yee, Michelle Geddes, Nancy Zhu, April Shamy, Heather A Leitch, Grace Christou, Versha Banerji, Leber Brian, Dina Khalaf, Eve St-Hilaire, Nicholas Finn, Thomas Nevill, Mary-Margaret Keating, John Storring, Robert Delage, Anne Parmentier, Aksharh Thambipillai, Mohammed Siddiqui, Christopher Westcott, Chris Cameron, Alexandre Mamedov, Paul Spin, Derek Tang
A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry. Leukemia & lymphoma (2022)
Tom Martin, Saad Z Usmani, Jordan M Schecter, Martin Vogel, Carolyn C Jackson, William Deraedt, Hong Tian, Tzu-Min Yeh, Arnob Banerjee, Lida Pacaud, Ashraf Garrett, Anja Haltner, Chris Cameron, Suzy Van Sanden, Joris Diels, Satish Valluri, Imtiaz A Samjoo
Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma. Current medical research and opinion 37 (10) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Paul Spin, Susan Lavinia Greco, Chris Cameron, Róisín Brennan, Frank Dahlke, Nicholas Adlard
Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses. Current medical research and opinion 37 (11) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Susan Lavinia Greco, Melody Zhao, Chris Cameron, Dieter A Häring, Dee Stoneman, Luisa Klotz, Nicholas Adlard
Letter in reply. Journal of comparative effectiveness research 10 (17) (2021)
Hope S Rugo, Anja Haltner, Lin Zhan, Anh Tran, Eustratios Bananis, Becky Hooper, Debanjali Mitra, Chris Cameron
Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer. Journal of comparative effectiveness research 10 (6) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Susan Lavinia Greco, Melody Zhao, Chris Cameron, Dieter A Häring, Dee Stoneman, Luisa Klotz, Nicholas Adlard
Efficacy classification of modern therapies in multiple sclerosis. Journal of comparative effectiveness research 10 (6) (2021)
Ernest H Law, Roya Gavanji, Sarah Walsh, Anja Haltner, Rebecca McTavish, Chris Cameron
Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points. Journal of comparative effectiveness research (2021)
Nadia Harbeck, Meaghan Bartlett, Dean Spurden, Becky Hooper, Lin Zhan, Emily Rosta, Chris Cameron, Debanjali Mitra, Anna Zhou
CDK4/6 inhibitors in HR+/HER2- advanced/metastatic breast cancer: a systematic literature review of real-world evidence studies. Future oncology (London, England) 17 (16) (2021)
Imtiaz A Samjoo, Evelyn Worthington, Susan Lavinia Greco, Melody Zhao, Chris Cameron, Dieter A Häring, Dee Stoneman, Luisa Klotz, Nicholas Adlard
Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis. Journal of comparative effectiveness research 9 (18) (2020)
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Chris Cameron, Richard Nicholas, Frank Dahlke, Nicholas Adlard
The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis. Current medical research and opinion 36 (7) (2020)
Imtiaz A Samjoo, Evelyn Worthington, Anja Haltner, Chris Cameron, Richard Nicholas, Nicolas Rouyrre, Frank Dahlke, Nicholas Adlard
Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis. Current medical research and opinion 36 (7) (2020)
Chris Cameron, Abhishek Varu, Arthur Lau, Mahdi Gharaibeh, Marcelo Paulino, Raina Rogoza
Incorporating adjustments for variability in control group response rates in network meta-analysis: a case study of biologics for rheumatoid arthritis. BMC medical research methodology 19 (1) (2019)
Florence R Wilson, Megan E Coombes, Christine Brezden-Masley, Mariya Yurchenko, Quinlan Wylie, Reuben Douma, Abhishek Varu, Brian Hutton, Becky Skidmore, Chris Cameron
Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis. Systematic reviews 7 (1) (2018)
Chris Cameron, Doug Coyle, Trevor Richter, Shannon Kelly, Kasandra Gauthier, Sabine Steiner, Marc Carrier, Kathryn Coyle, Annie Bai, Kristen Moulton, Tammy Clifford, George Wells
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation. BMJ open 4 (6) (2014)